[HTML][HTML] Review of hybrid PLGA nanoparticles: Future of smart drug delivery and theranostics medicine

J Ghitman, EI Biru, R Stan, H Iovu - Materials & Design, 2020 - Elsevier
The concept of PLGA-lipid hybrid nanoparticles arose as a motivation for developing drug
delivery systems with versatile physical and chemical properties, unequivocal therapeutic …

Development strategies and prospects of nano-based smart pesticide formulation

X Zhao, H Cui, Y Wang, C Sun, B Cui… - Journal of agricultural …, 2017 - ACS Publications
Pesticides are important inputs for enhancing crop productivity and preventing major
biological disasters. However, more than 90% of pesticides run off into the environment and …

[HTML][HTML] PLGA nanoparticle preparations by emulsification and nanoprecipitation techniques: Effects of formulation parameters

KY Hernández-Giottonini, RJ Rodríguez-Córdova… - Rsc Advances, 2020 - pubs.rsc.org
This study presents the influence of the primary formulation parameters on the formation of
poly-DL-lactic-co-glycolic nanoparticles by the emulsification-solvent evaporation, and the …

[HTML][HTML] Manufacturing techniques and surface engineering of polymer based nanoparticles for targeted drug delivery to cancer

Y Wang, P Li, T Truong-Dinh Tran, J Zhang, L Kong - Nanomaterials, 2016 - mdpi.com
The evolution of polymer based nanoparticles as a drug delivery carrier via pharmaceutical
nano/microencapsulation has greatly promoted the development of nano-and micro …

Nanomedicine scale-up technologies: feasibilities and challenges

R Paliwal, RJ Babu, S Palakurthi - Aaps Pharmscitech, 2014 - Springer
Nanomedicine refers to biomedical and pharmaceutical applications of nanosized cargos of
drugs/vaccine/DNA therapeutics including nanoparticles, nanoclusters, and nanospheres …

Designing, structural determination and biological effects of rifaximin loaded chitosan-carboxymethyl chitosan nanogel

SA Algharib, A Dawood, K Zhou, D Chen, C Li… - Carbohydrate …, 2020 - Elsevier
Due to the poor solubility and permeability of rifaximin (RFX), it is not effective against
intracellular pathogens although it shows strong activity against most bacteria. To develop …

[HTML][HTML] Solid lipid based nanocarriers: An overview/Nanonosači na bazi čvrstih lipida: Pregled

C Pardeshi, P Rajput, V Belgamwar, A Tekade… - Acta …, 2012 - sciendo.com
In the era of nanoparticulate controlled and site specific drug delivery systems, use of solid
lipids to produce first generation lipid nanoparticles, solid lipid nanoparticles (SLN), became …

Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye

Y Wu, LK Vora, Y Wang, MF Adrianto, IA Tekko… - European Journal of …, 2021 - Elsevier
Abstract Treatment of neovascular ocular diseases involves intravitreal injections of
therapeutic proteins using conventional hypodermic needles every 4–6 weeks. Due to the …

Microfluidic assembly of “Turtle-Like” shaped solid lipid nanoparticles for lysozyme delivery

F Sommonte, I Arduino, RM Iacobazzi, M Tiboni… - International Journal of …, 2023 - Elsevier
After two decades of research in the field of nanomedicine, nanoscale delivery systems for
biologicals are becoming clinically relevant tools. Microfluidic-based fabrication processes …

Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition

P Shah, K Chavda, B Vyas, S Patel - Drug delivery and translational …, 2021 - Springer
Linagliptin (LGP), a novel anti-diabetic drug, is a DPP-4 inhibitor used in the treatment of
type II diabetes. One of the major disadvantages of LGP is its low oral bioavailability (29.5%) …